Get Patent Opposition Report for Adamed Pharma

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore patent oppositions filed by Adamed Pharma against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3697392Tablets Comprising Tamsulosin And SolifenacinSYNTHONAug 9, 2024
EP2959894S1P Receptor Modulators For Treating Multiple SclerosisNOVARTISJul 11, 2023

Explore Adamed Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP2919815Sep 6, 2017A Pharmaceutical Composition Containing An Ace Inhibitor And A Calcium Channel Blocker1